SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-064629
Filing Date
2022-05-25
Accepted
2022-05-25 16:05:42
Documents
2
Period of Report
2022-05-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2215800d1_3.html 3  
1 OWNERSHIP DOCUMENT tm2215800d1_3.xml 3 1736
2 EXHIBIT 24 tm2215800d1_ex24.htm EX-24 9384
  Complete submission text file 0001104659-22-064629.txt   12532
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVENUE THERAPEUTICS, INC. 1140 AVENUE OF THE AMERICAS, FLOOR 9 NEW YORK NY 10036
Business Address
Jin David (Reporting) CIK: 0001930732 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38114 | Film No.: 22962901